대한 소아알레르기 호흡기학회 소아청소년 아토피피부염 진료지침: 1편. 피부관리 및 국소치료
The KAPARD guidelines for atopic dermatitis in children and adolescents: Part I. Skin care and topical treatment
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Atopic dermatitis is one of the most common chronic skin inflammatory diseases in children. Appropriate treatment is difficult due to chronic course with frequent exacerbations, especially in children. Treatment requires caution due to a lack of safety data and information regarding the long-term prognosis of management strategies. The Korean Academy of Pediatric Allergy and Respiratory Disease (KAPARD) published the Atopic Dermatitis Treatment Guidelines in 2008, which has been used to direct atopic dermatitis treatment. Accumulating evidence suggests that the guidelines need to be updated regarding bathing methods (duration of bath, temperature, etc.), wet wrap therapy, and topical treatments in line with environmental changes over time and changes in the management strategies of atopic dermatitis. This KAPARD guidelines for atopic dermatitis applied an adaptation based on a systematic review and analysis of selected literature. They are intended to support front-line doctors treating pediatric and adolescent patients with atopic dermatitis in making reasoned, safe, effective empirical treatment decisions. In Part I of the KAPARD guidelines for atopic dermatitis, we included evidence-based skin care management strategies and topical treatment options.
Abstract
Atopic dermatitis is one of the most common chronic skin inflammatory diseases in children. Appropriate treatment is difficult due to chronic course with frequent exacerbations, especially in children. Treatment requires caution due to a lack of safety data and information regarding the long-term prognosis of management strategies. The Korean Academy of Pediatric Allergy and Respiratory Disease (KAPARD) published the Atopic Dermatitis Treatment Guidelines in 2008, which has been used to direct atopic dermatitis treatment. Accumulating evidence suggests that the guidelines need to be updated regarding bathing methods (duration of bath, temperature, etc.), wet wrap therapy, and topical treatments in line with environmental changes over time and changes in the management strategies of atopic dermatitis. This KAPARD guidelines for atopic dermatitis applied an adaptation based on a systematic review and analysis of selected literature. They are intended to support front-line doctors treating pediatric and adolescent patients with atopic dermatitis in making reasoned, safe, effective empirical treatment decisions. In Part I of the KAPARD guidelines for atopic dermatitis, we included evidence-based skin care management strategies and topical treatment options.
참고문헌 (33)
- Park YM, "Risk factors of atopic dermatitis in Korean schoolchildren : 2010 international study of asthma and allergies in childhood", Asian Pac J Allergy Immunol, 34, pp.65~72 (2016)
- Kim JH, "Cascade of atopic dermatitis comorbidities in children after birth for 15 years", Allergy, 79, pp.153~163 (2024)
- Ahn J, "Unraveling the link between atopic dermatitis and autoimmune diseases in children : insights from a large-scale cohort study with 15-year follow-up and shared gene ontology analysis", Allergol Int, 73, pp.243~254 (2024)
- "The guideline for atopic dermatitis in children and adolescents" (2008)[URL]
- Wollenberg A, "Consensus-based European guidelines for treatment of atopic eczema(atopic dermatitis)in adults and children : part I", J Eur Acad Dermatol Venereol, 32, pp.657~682 (2018)
- Saeki H, "Executive summary : Japanese guidelines for atopic dermatitis(ADGL)2021", Allergol Int, 71, pp.448~458 (2022)
- LePoidevin LM, "A comparison of international management guidelines for atopic dermatitis", Pediatr Dermatol, 36, pp.36~65 (2019)
- Weidinger S, "Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations", J Allergy Clin Immunol, 118, pp.214~219 (2006)
- Wollenberg A, "ETFAD", EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children, 2020, pp.34, 2717~2744
- Akerstrom U, "Comparison of moisturizing creams for the prevention of atopic dermatitis relapse : a randomized double-blind controlled multicentre clinical trial", Acta Derm Venereol, 95, pp.587~592 (2015)
- Tay YK, "Guidelines for the management of atopic dermatitis in Singapore", Ann Acad Med Singap, 45, pp.439~450 (2016)
- Rubel D, "Consensus guidelines for the management of atopic dermatitis : an Asia-Pacific perspective", J Dermatol, 40, pp.160~171 (2013)
- Wollenberg A, "ETFAD", EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients, 2016, pp.30, 729~747
- Kim JE, "Consensus guidelines for the treatment of atopic dermatitis in Korea(Part I) : general management and topical treatment", Ann Dermatol, 27, pp.563~577 (2015)
- Wollenberg A, "Evolution of conventional therapy in atopic dermatitis", Immunol Allergy Clin North Am, 30, pp.351~368 (2010)
- Grimalt R, "The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis : a randomized controlled study", Dermatology, 214, pp.61~67 (2007)
- Dinkloh A, "Contact sensitization in patients with suspected cosmetic intolerance : results of the IVDK 2006-2011", J Eur Acad Dermatol Venereol, 29, pp.1071~1081 (2015)
- Wollenberg A, "Viral infections in atopic dermatitis : pathogenic aspects and clinical management", J Allergy Clin Immunol, 112, pp.667~674 (2003)
- Lee JH, "Consensus update for systemic treatment of atopic dermatitis", Ann Dermatol, 33, pp.497~514 (2021)
- Nicol NH, "Wet wrap therapy in moderate to severe atopic dermatitis", Immunol Allergy Clin North Am, 37, pp.123~139 (2017)
- Devillers AC, "Wet-wrap treatment in children with atopic dermatitis : a practical guideline", Pediatr Dermatol, 29, pp.24~27 (2012)
- Wong SM, "Efficacy and safety of sodium hypochlorite(bleach)baths in patients with moderate to severe atopic dermatitis in Malaysia", J Dermatol, 40, pp.874~880 (2013)
- Hon KL, "Efficacy of sodium hypochlorite(bleach)baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema : a randomized, placebo-controlled cross-over trial", J Dermatolog Treat, 27, pp.156~162 (2016)
- Katoh N, "Clinical practice guidelines for the management of atopic dermatitis 2018", J Dermatol, 46, pp.1053~1101 (2019)
- Mohan GC, "Comparison of dermatology and allergy guidelines for atopic dermatitis management", JAMA Dermatol, 151, pp.1009~1013 (2015)
- Ruzicka T, "A short-term trial of tacrolimus ointment for atopic dermatitis. European tacrolimus multicenter atopic dermatitis study group", N Engl J Med, 337, pp.816~821 (1997)
- Thaci D, "Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis : facts and controversies", Clin Dermatol, 28, pp.52~56 (2010)
- Luger T, "Pimecrolimus in atopic dermatitis : consensus on safety and the need to allow use in infants", Pediatr Allergy Immunol, 26, pp.306~315 (2015)
- Paller AS, "No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis", J Am Acad Dermatol, 83, pp.375~381 (2020)
- Lubbe J, "Saurat JH. Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment", Dermatology, 201, pp.249~251 (2000)
- Wetzel S, "Eczema molluscatum in tacrolimus treated atopic dermatitis", Eur J Dermatol, 14, pp.73~74 (2004)
- Mayser P, "Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study", Skin Pharmacol Physiol, 19, pp.153~158 (2006)
- Song Y, "A reporting tool for adapted guidelines in health care : the RIGHT-Ad@pt Checklist", Ann Intern Med, 175, pp.710~719 (2022)